Immunohematology Market size is projected to reach US$ 3.28 Bn at the end of the forecast period at a CAGR of 4%. The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.To know about the Research Methodology:-Request Free Sample Report Immunohematology is dealing with the study of antibodies and RBC antigens that are mainly related to blood transfusion. The basic rinciple of immunohematology is the reaction between antigens and antibodies, which either causes haemolysis of RBC agglutination. Immunohematology technique is mainly used to detect the presence of a particular antigen in the blood. The key factor that drives the Immunohematology market growth includes an increase in investment by public and private organizations in constructing blood banks, which ultimately helps in increasing the sales of immunohematology devices. The growing incidence of blood cancer and blood-related diseases, such as sickle cell disease, is leading to an increase in the demand for blood transfusion procedures. These factors eventually drive the Global Immunohematology Market. However, the high cost of analyzers and reagents and the lack of skilled professionals may limit the Global Immunohematology Market growth. According to product segment, Immunohematology reagents are expected to dominate the market in the forecast period, owing to the increasing use of reagents in the blood banks for immunohematology tests, rising number of customization for reagents used during tests, and growing demand for regents due to increased use of immunohematology in diagnostic technologies. Region-wise, North America is projected to dominate the Global Immunohematology Market in the forecast period, owing to the early introduction of highly developed techniques, the presence of a highly skilled workforce, diagnostics centers, and blood banks, and availability of advanced healthcare infrastructure. The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding the Global Immunohematology Market dynamics, structure by identifying and analyzing the market segments and project the global market size. Further, the report also focuses on the competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTER’s analysis, and SWOT analysis to address questions of shareholders to prioritizing the efforts and investment in the near future to the emerging segment in the global gram Immunohematology market.
Immunohematology Market Scope: Inquire before buying
Global Immunohematology Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 2.49 Bn. Forecast Period 2023 to 2029 CAGR: 4% Market Size in 2029: US $ 3.28 Bn. Segments Covered: by Product Immunohematology Analyzer Immunohematology Reagents by Application Cancer Blood Typing Antibody Screening Blood-related diseases HIV Hepatitis by End-user Hospitals Academic and Research Institutes Diagnostics and Reference Laboratories Blood Banks Immunohematology Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Immunohematology Market Key Players
1.Bio-Rad Laboratories, Inc. 2.Immucor 3.Grifols 4.BD (Becton Dickinson) 5.Hologic, Inc. 6.Siemens Healthcare GmbH 7.ThermoFisher 8.Abbott 9.Beckman Coulter, Inc. 10.Ortho Clinical Diagnostics 11.Roche Diagnostics Corporation 12.Merck KGaA 13.Cardinal Health Inc. 14.CSL Ltd. 15.Danaher Corp. 16.MTC Invitro Diagnostics AG 17.F. Hoffmann-La Roche Ltd. 18.Antisel Frequently Asked Questions: 1. Which region has the largest share in Global Immunohematology Market? Ans: North America region held the highest share in 2022. 2. What is the growth rate of Global Immunohematology Market? Ans: The Global Immunohematology Market is growing at a CAGR of 4% during forecasting period 2023-2029. 3. What is scope of the Global Immunohematology market report? Ans: Global Immunohematology Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Immunohematology market? Ans: The important key players in the Global Immunohematology Market are – Bio-Rad Laboratories, Inc., Immucor, Grifols, BD (Becton Dickinson), Hologic, Inc., Siemens Healthcare GmbH, ThermoFisher, Abbott, Beckman Coulter, Inc., Ortho Clinical Diagnostics, Roche Diagnostics Corporation, Merck KGaA, Cardinal Health Inc., CSL Ltd., Danaher Corp., MTC Invitro Diagnostics AG, F. Hoffmann-La Roche Ltd., and Antisel 5. What is the study period of this market? Ans: The Global Immunohematology Market is studied from 2022 to 2029.
Global Immunohematology Market
1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Immunohematology Market Size, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Immunohematology Market Analysis and Forecast 6.1. Global Immunohematology Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Immunohematology Market Analysis and Forecast, by Product 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Immunohematology Market Value Share Analysis, by Product 7.4. Global Immunohematology Market Size (US$ Bn) Forecast, by Product 7.5. Global Immunohematology Market Analysis, by Product 7.6. Global Immunohematology Market Attractiveness Analysis, by Product 8. Global Immunohematology Market Analysis and Forecast, by Application 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Immunohematology Market Value Share Analysis, by Application 8.4. Global Immunohematology Market Size (US$ Bn) Forecast, by Application 8.5. Global Immunohematology Market Analysis, by Application 8.6. Global Immunohematology Market Attractiveness Analysis, by Application 9. Global Immunohematology Market Analysis and Forecast, by End-user 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Immunohematology Market Value Share Analysis, by End-user 9.4. Global Immunohematology Market Size (US$ Bn) Forecast, by End-user 9.5. Global Immunohematology Market Analysis, by End-user 9.6. Global Immunohematology Market Attractiveness Analysis, by End-user 10. Global Immunohematology Market Analysis, by Region 10.1. Global Immunohematology Market Value Share Analysis, by Region 10.2. Global Immunohematology Market Size (US$ Bn) Forecast, by Region 10.3. Global Immunohematology Market Attractiveness Analysis, by Region 11. North America Immunohematology Market Analysis 11.1. Key Findings 11.2. North America Immunohematology Market Overview 11.3. North America Immunohematology Market Value Share Analysis, by Product 11.4. North America Immunohematology Market Forecast, by Product 11.4.1. Immunohematology Analyzer 11.4.2. Immunohematology Reagents 11.5. North America Immunohematology Market Value Share Analysis, by Application 11.6. North America Immunohematology Market Forecast, by Application 11.6.1. Cancer Blood Typing 11.6.2. Antibody Screening 11.6.3. Blood-related diseases 11.6.4. HIV 11.6.5. Hepatitis 11.7. North America Immunohematology Market Value Share Analysis, by End-user 11.8. North America Immunohematology Market Forecast, by End-user 11.8.1. Hospitals 11.8.2. Academic and Research Institutes 11.8.3. Diagnostics and Reference Laboratories 11.8.4. Blood Banks 11.9. North America Immunohematology Market Value Share Analysis, by Country 11.10. North America Immunohematology Market Forecast, by Country 11.10.1. U.S. 11.10.2. Canada 11.11. North America Immunohematology Market Analysis, by Country 11.12. U.S. Immunohematology Market Forecast, by Product 11.12.1. Immunohematology Analyzer 11.12.2. Immunohematology Reagents 11.13. U.S. Immunohematology Market Forecast, by Application 11.13.1. Cancer Blood Typing 11.13.2. Antibody Screening 11.13.3. Blood-related diseases 11.13.4. HIV 11.13.5. Hepatitis 11.14. U.S. Immunohematology Market Forecast, by End-user 11.14.1. Hospitals 11.14.2. Academic and Research Institutes 11.14.3. Diagnostics and Reference Laboratories 11.14.4. Blood Banks 11.15. Canada Immunohematology Market Forecast, by Product 11.15.1. Immunohematology Analyzer 11.15.2. Immunohematology Reagents 11.16. Steel Canada Immunohematology Market Forecast, by Application 11.16.1. Cancer Blood Typing 11.16.2. Antibody Screening 11.16.3. Blood-related diseases 11.16.4. HIV 11.16.5. Hepatitis 11.17. Canada Immunohematology Market Forecast, by End-user 11.17.1. Hospitals 11.17.2. Academic and Research Institutes 11.17.3. Diagnostics and Reference Laboratories 11.17.4. Blood Banks 11.18. North America Immunohematology Market Attractiveness Analysis 11.18.1. By Product 11.18.2. By Application 11.18.3. By End-user 11.19. PEST Analysis 11.20. Key Trends 11.21. Key Developments 12. Europe Immunohematology Market Analysis 12.1. Key Findings 12.2. Europe Immunohematology Market Overview 12.3. Europe Immunohematology Market Value Share Analysis, by Product 12.4. Europe Immunohematology Market Forecast, by Product 12.4.1. Immunohematology Analyzer 12.4.2. Immunohematology Reagents 12.5. Europe Immunohematology Market Value Share Analysis, by Application 12.6. Europe Immunohematology Market Forecast, by Application 12.6.1. Cancer Blood Typing 12.6.2. Antibody Screening 12.6.3. Blood-related diseases 12.6.4. HIV 12.6.5. Hepatitis 12.7. Europe Immunohematology Market Value Share Analysis, by End-user 12.8. Europe Immunohematology Market Forecast, by End-user 12.8.1. Hospitals 12.8.2. Academic and Research Institutes 12.8.3. Diagnostics and Reference Laboratories 12.8.4. Blood Banks 12.9. Europe Immunohematology Market Value Share Analysis, by Country 12.10. Europe Immunohematology Market Forecast, by Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Rest of Europe 12.11. Europe Immunohematology Market Analysis, by Country 12.12. Germany Immunohematology Market Forecast, by Product 12.12.1. Immunohematology Analyzer 12.12.2. Immunohematology Reagents 12.13. Germany Immunohematology Market Forecast, by Application 12.13.1. Cancer Blood Typing 12.13.2. Antibody Screening 12.13.3. Blood-related diseases 12.13.4. HIV 12.13.5. Hepatitis 12.14. Germany Immunohematology Market Forecast, by End-user 12.14.1. Hospitals 12.14.2. Academic and Research Institutes 12.14.3. Diagnostics and Reference Laboratories 12.14.4. Blood Banks 12.15. U.K. Immunohematology Market Forecast, by Product 12.15.1. Immunohematology Analyzer 12.15.2. Immunohematology Reagents 12.16. U.K. Immunohematology Market Forecast, by Application 12.16.1. Cancer Blood Typing 12.16.2. Antibody Screening 12.16.3. Blood-related diseases 12.16.4. HIV 12.16.5. Hepatitis 12.17. U.K. Immunohematology Market Forecast, by End-user 12.17.1. Hospitals 12.17.2. Academic and Research Institutes 12.17.3. Diagnostics and Reference Laboratories 12.17.4. Blood Banks 12.18. France Immunohematology Market Forecast, by Product 12.18.1. Immunohematology Analyzer 12.18.2. Immunohematology Reagents 12.19. France Immunohematology Market Forecast, by Application 12.19.1. Cancer Blood Typing 12.19.2. Antibody Screening 12.19.3. Blood-related diseases 12.19.4. HIV 12.19.5. Hepatitis 12.20. France Immunohematology Market Forecast, by End-user 12.20.1. Hospitals 12.20.2. Academic and Research Institutes 12.20.3. Diagnostics and Reference Laboratories 12.20.4. Blood Banks 12.21. Italy Immunohematology Market Forecast, by Product 12.21.1. Immunohematology Analyzer 12.21.2. Immunohematology Reagents 12.22. Italy Immunohematology Market Forecast, by Application 12.22.1. Cancer Blood Typing 12.22.2. Antibody Screening 12.22.3. Blood-related diseases 12.22.4. HIV 12.22.5. Hepatitis 12.23. Italy Immunohematology Market Forecast, by End-user 12.23.1. Hospitals 12.23.2. Academic and Research Institutes 12.23.3. Diagnostics and Reference Laboratories 12.23.4. Blood Banks 12.24. Spain Immunohematology Market Forecast, by Product 12.24.1. Immunohematology Analyzer 12.24.2. Immunohematology Reagents 12.25. Spain Immunohematology Market Forecast, by Application 12.25.1. Cancer Blood Typing 12.25.2. Antibody Screening 12.25.3. Blood-related diseases 12.25.4. HIV 12.25.5. Hepatitis 12.26. Spain Immunohematology Market Forecast, by End-user 12.26.1. Hospitals 12.26.2. Academic and Research Institutes 12.26.3. Diagnostics and Reference Laboratories 12.26.4. Blood Banks 12.27. Rest of Europe Immunohematology Market Forecast, by Product 12.27.1. Immunohematology Analyzer 12.27.2. Immunohematology Reagents 12.28. Rest of Europe Immunohematology Market Forecast, by Application 12.28.1. Cancer Blood Typing 12.28.2. Antibody Screening 12.28.3. Blood-related diseases 12.28.4. HIV 12.28.5. Hepatitis 12.29. Rest Of Europe Immunohematology Market Forecast, by End-user 12.29.1. Hospitals 12.29.2. Academic and Research Institutes 12.29.3. Diagnostics and Reference Laboratories 12.29.4. Blood Banks 12.30. Europe Immunohematology Market Attractiveness Analysis 12.30.1. By Product 12.30.2. By Application 12.30.3. By End-user 12.31. PEST Analysis 12.32. Key Trends 12.33. Key Developments 13. Asia Pacific Immunohematology Market Analysis 13.1. Key Findings 13.2. Asia Pacific Immunohematology Market Overview 13.3. Asia Pacific Immunohematology Market Value Share Analysis, by Product 13.4. Asia Pacific Immunohematology Market Forecast, by Product 13.4.1. Immunohematology Analyzer 13.4.2. Immunohematology Reagents 13.5. Asia Pacific Immunohematology Market Value Share Analysis, by Application 13.6. Asia Pacific Immunohematology Market Forecast, by Application 13.6.1. Cancer Blood Typing 13.6.2. Antibody Screening 13.6.3. Blood-related diseases 13.6.4. HIV 13.6.5. Hepatitis 13.7. Asia Pacific Immunohematology Market Value Share Analysis, by End-user 13.8. Asia Pacific Immunohematology Market Forecast, by End-user 13.8.1. Hospitals 13.8.2. Academic and Research Institutes 13.8.3. Diagnostics and Reference Laboratories 13.8.4. Blood Banks 13.9. Asia Pacific Immunohematology Market Value Share Analysis, by Country 13.10. Asia Pacific Immunohematology Market Forecast, by Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. ASEAN 13.10.5. Rest of Asia Pacific 13.11. Asia Pacific Immunohematology Market Analysis, by Country 13.12. China Immunohematology Market Forecast, by Product 13.12.1. Immunohematology Analyzer 13.12.2. Immunohematology Reagents 13.13. China Immunohematology Market Forecast, by Application 13.13.1. Cancer Blood Typing 13.13.2. Antibody Screening 13.13.3. Blood-related diseases 13.13.4. HIV 13.13.5. Hepatitis 13.14. China Immunohematology Market Forecast, by End-user 13.14.1. Hospitals 13.14.2. Academic and Research Institutes 13.14.3. Diagnostics and Reference Laboratories 13.14.4. Blood Banks 13.15. India Immunohematology Market Forecast, by Product 13.15.1. Immunohematology Analyzer 13.15.2. Immunohematology Reagents 13.16. India Immunohematology Market Forecast, by Application 13.16.1. Cancer Blood Typing 13.16.2. Antibody Screening 13.16.3. Blood-related diseases 13.16.4. HIV 13.16.5. Hepatitis 13.17. India Immunohematology Market Forecast, by End-user 13.17.1. Hospitals 13.17.2. Academic and Research Institutes 13.17.3. Diagnostics and Reference Laboratories 13.17.4. Blood Banks 13.18. Japan Immunohematology Market Forecast, by Product 13.18.1. Immunohematology Analyzer 13.18.2. Immunohematology Reagents 13.19. Japan Immunohematology Market Forecast, by Application 13.19.1. Cancer Blood Typing 13.19.2. Antibody Screening 13.19.3. Blood-related diseases 13.19.4. HIV 13.19.5. Hepatitis 13.20. Japan Immunohematology Market Forecast, by End-user 13.20.1. Hospitals 13.20.2. Academic and Research Institutes 13.20.3. Diagnostics and Reference Laboratories 13.20.4. Blood Banks 13.21. ASEAN Immunohematology Market Forecast, by Product 13.21.1. Immunohematology Analyzer 13.21.2. Immunohematology Reagents 13.22. ASEAN Immunohematology Market Forecast, by Application 13.22.1. Cancer Blood Typing 13.22.2. Antibody Screening 13.22.3. Blood-related diseases 13.22.4. HIV 13.22.5. Hepatitis 13.23. ASEAN Immunohematology Market Forecast, by End-user 13.23.1. Hospitals 13.23.2. Academic and Research Institutes 13.23.3. Diagnostics and Reference Laboratories 13.23.4. Blood Banks 13.24. Rest of Asia Pacific Immunohematology Market Forecast, by Product 13.24.1. Immunohematology Analyzer 13.24.2. Immunohematology Reagents 13.25. Rest of Asia Pacific Immunohematology Market Forecast, by Application 13.25.1. Cancer Blood Typing 13.25.2. Antibody Screening 13.25.3. Blood-related diseases 13.25.4. HIV 13.25.5. Hepatitis 13.26. Rest of Asia Pacific Immunohematology Market Forecast, by End-user 13.26.1. Hospitals 13.26.2. Academic and Research Institutes 13.26.3. Diagnostics and Reference Laboratories 13.26.4. Blood Banks 13.27. Asia Pacific Immunohematology Market Attractiveness Analysis 13.27.1. By Product 13.27.2. By Application 13.27.3. By End-user 13.28. PEST Analysis 13.29. Key Trends 13.30. Key Developments 14. Middle East & Africa Immunohematology Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Immunohematology Market Overview 14.3. Middle East & Africa Immunohematology Market Value Share Analysis, by Product 14.4. Middle East & Africa Immunohematology Market Forecast, by Product 14.4.1. Immunohematology Analyzer 14.4.2. Immunohematology Reagents 14.5. Middle East & Africa Immunohematology Market Value Share Analysis, by Application 14.6. Middle East & Africa Immunohematology Market Forecast, by Application 14.6.1. Cancer Blood Typing 14.6.2. Antibody Screening 14.6.3. Blood-related diseases 14.6.4. HIV 14.6.5. Hepatitis 14.7. Middle East & Africa Immunohematology Market Value Share Analysis, by End-user 14.8. Middle East & Africa Immunohematology Market Forecast, by End-user 14.8.1. Hospitals 14.8.2. Academic and Research Institutes 14.8.3. Diagnostics and Reference Laboratories 14.8.4. Blood Banks 14.9. Middle East & Africa Immunohematology Market Value Share Analysis, by Country 14.10. Middle East & Africa Immunohematology Market Forecast, by Country 14.10.1. GCC 14.10.2. South Africa 14.10.3. Rest of Middle East & Africa 14.11. Middle East & Africa Immunohematology Market Analysis, by Country 14.12. GCC Immunohematology Market Forecast, by Product 14.12.1. Immunohematology Analyzer 14.12.2. Immunohematology Reagents 14.13. GCC Immunohematology Market Forecast, by Application 14.13.1. Cancer Blood Typing 14.13.2. Antibody Screening 14.13.3. Blood-related diseases 14.13.4. HIV 14.13.5. Hepatitis 14.14. GCC Immunohematology Market Forecast, by End-user 14.14.1. Hospitals 14.14.2. Academic and Research Institutes 14.14.3. Diagnostics and Reference Laboratories 14.14.4. Blood Banks 14.15. South Africa Immunohematology Market Forecast, by Product 14.15.1. Immunohematology Analyzer 14.15.2. Immunohematology Reagents 14.16. South Africa Immunohematology Market Forecast, by Application 14.16.1. Cancer Blood Typing 14.16.2. Antibody Screening 14.16.3. Blood-related diseases 14.16.4. HIV 14.16.5. Hepatitis 14.17. South Africa Immunohematology Market Forecast, by End-user 14.17.1. Hospitals 14.17.2. Academic and Research Institutes 14.17.3. Diagnostics and Reference Laboratories 14.17.4. Blood Banks 14.18. Rest of Middle East & Africa Immunohematology Market Forecast, by Product 14.18.1. Immunohematology Analyzer 14.18.2. Immunohematology Reagents 14.19. Rest of Middle East & Africa Immunohematology Market Forecast, by Application 14.19.1. Cancer Blood Typing 14.19.2. Antibody Screening 14.19.3. Blood-related diseases 14.19.4. HIV 14.19.5. Hepatitis 14.20. Rest of Middle East & Africa Immunohematology Market Forecast, by End-user 14.20.1. Hospitals 14.20.2. Academic and Research Institutes 14.20.3. Diagnostics and Reference Laboratories 14.20.4. Blood Banks 14.21. Middle East & Africa Immunohematology Market Attractiveness Analysis 14.21.1. By Product 14.21.2. By Application 14.21.3. By End-user 14.22. PEST Analysis 14.23. Key Trends 14.24. Key Developments 15. South America Immunohematology Market Analysis 15.1. Key Findings 15.2. South America Immunohematology Market Overview 15.3. South America Immunohematology Market Value Share Analysis, by Product 15.4. South America Immunohematology Market Forecast, by Product 15.4.1. Immunohematology Analyzer 15.4.2. Immunohematology Reagents 15.5. South America Immunohematology Market Value Share Analysis, by Application 15.6. South America Immunohematology Market Forecast, by Application 15.6.1. Cancer Blood Typing 15.6.2. Antibody Screening 15.6.3. Blood-related diseases 15.6.4. HIV 15.6.5. Hepatitis 15.7. South America Immunohematology Market Value Share Analysis, by End-user 15.8. South America Immunohematology Market Forecast, by End-user 15.8.1. Hospitals 15.8.2. Academic and Research Institutes 15.8.3. Diagnostics and Reference Laboratories 15.8.4. Blood Banks 15.9. South America Immunohematology Market Value Share Analysis, by Country 15.10. South America Immunohematology Market Forecast, by Country 15.10.1. Brazil 15.10.2. Mexico 15.10.3. Rest of South America 15.11. South America Immunohematology Market Analysis, by Country 15.12. Brazil Immunohematology Market Forecast, by Product 15.12.1. Immunohematology Analyzer 15.12.2. Immunohematology Reagents 15.13. Brazil Immunohematology Market Forecast, by Application 15.13.1. Cancer Blood Typing 15.13.2. Antibody Screening 15.13.3. Blood-related diseases 15.13.4. HIV 15.13.5. Hepatitis 15.14. Brazil Immunohematology Market Forecast, by End-user 15.14.1. Hospitals 15.14.2. Academic and Research Institutes 15.14.3. Diagnostics and Reference Laboratories 15.14.4. Blood Banks 15.15. Mexico Immunohematology Market Forecast, by Product 15.15.1. Immunohematology Analyzer 15.15.2. Immunohematology Reagents 15.16. Mexico Immunohematology Market Forecast, by Application 15.16.1. Cancer Blood Typing 15.16.2. Antibody Screening 15.16.3. Blood-related diseases 15.16.4. HIV 15.16.5. Hepatitis 15.17. Mexico Immunohematology Market Forecast, by End-user 15.17.1. Hospitals 15.17.2. Academic and Research Institutes 15.17.3. Diagnostics and Reference Laboratories 15.17.4. Blood Banks 15.18. Rest of South America Immunohematology Market Forecast, by Product 15.18.1. Immunohematology Analyzer 15.18.2. Immunohematology Reagents 15.19. Rest of South America Immunohematology Market Forecast, by Application 15.19.1. Cancer Blood Typing 15.19.2. Antibody Screening 15.19.3. Blood-related diseases 15.19.4. HIV 15.19.5. Hepatitis 15.20. Rest of South America Immunohematology Market Forecast, by End-user 15.20.1. Hospitals 15.20.2. Academic and Research Institutes 15.20.3. Diagnostics and Reference Laboratories 15.20.4. Blood Banks 15.21. South America Immunohematology Market Attractiveness Analysis 15.21.1. By Product 15.21.2. By Application 15.21.3. By End-user 15.22. PEST Analysis 15.23. Key Trends 15.24. Key Developments 16. Company Profiles 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A by Regions, Investment and Applications 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. Bio-Rad Laboratories, Inc. 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Product Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Development Footprint 16.3.2. Immucor 16.3.3. Grifols 16.3.4. BD (Becton Dickinson) 16.3.5. Hologic, Inc. 16.3.6. Siemens Healthcare GmbH 16.3.7. ThermoFisher 16.3.8. Abbott 16.3.9. Beckman Coulter, Inc. 16.3.10. Ortho Clinical Diagnostics 16.3.11. Roche Diagnostics Corporation 16.3.12. Merck KGaA 16.3.13. Cardinal Health Inc. 16.3.14. CSL Ltd. 16.3.15. Danaher Corp. 16.3.16. MTC Invitro Diagnostics AG 16.3.17. F. Hoffmann-La Roche Ltd. 16.3.18. Antisel 17. Primary Key Insights